Mmastodon WorldWorld first seen 10 h ago, last 8 min ago, peak #1
Imaavy approved as first treatment for warm autoimmune hemolytic anemia
Original: Recently, Imaavy (nipocalimab-aahu) becomes the first approved treatment for warm autoimmune hemolytic anemia (wAIHA). A
Imaavy (nipocalimab-aahu) has become the first approved treatment for warm autoimmune hemolytic anemia, a rare condition in which the immune system destroys the body's own red blood cells. The approval is being welcomed as a significant step for orphan drug development, offering patients with a previously untreatable disease a targeted option.
Why now: The drug's approval marks the first-ever treatment for a rare disease that previously had none, which is notable medical news.
Imaavynipocalimab-aahuwarm autoimmune hemolytic anemia
Rank over time, top of the chart is #1. 12 snapshots from 10 h ago to 8 min ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/955074